•
Dec 31, 2017

Edwards Lifesciences Q4 2017 Earnings Report

Total Revenue
$889M
Previous year: $768M
+15.7%
EPS
$0.31
Previous year: $0.25
+24.0%
Gross Profit
$653M
Previous year: $555M
+17.8%
Cash and Equivalents
$818M
Previous year: $930M
-12.0%
Free Cash Flow
$312M
Previous year: $641M
-51.3%
Total Assets
$5.67B
Previous year: $4.51B
+25.6%

Edwards Lifesciences

Edwards Lifesciences